loading
Precedente Chiudi:
$90.17
Aprire:
$90.65
Volume 24 ore:
476.54K
Relative Volume:
0.09
Capitalizzazione di mercato:
$132.22B
Reddito:
$15.91B
Utile/perdita netta:
$1.79B
Rapporto P/E:
110.87
EPS:
0.82
Flusso di cassa netto:
$1.89B
1 W Prestazione:
+3.66%
1M Prestazione:
+3.12%
6M Prestazione:
+19.99%
1 anno Prestazione:
+64.13%
Intervallo 1D:
Value
$90.23
$91.17
Intervallo di 1 settimana:
Value
$86.01
$91.08
Portata 52W:
Value
$53.93
$91.08

Boston Scientific Corp Stock (BSX) Company Profile

Name
Nome
Boston Scientific Corp
Name
Telefono
508-683-4000
Name
Indirizzo
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Name
Dipendente
48,000
Name
Cinguettio
@bostonsci
Name
Prossima data di guadagno
2024-10-23
Name
Ultimi documenti SEC
Name
BSX's Discussions on Twitter

Confronta BSX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
BSX 90.97 132.22B 15.91B 1.79B 1.89B 0.82
ABT 115.77 201.34B 41.22B 5.77B 6.49B 2.94
SYK 387.63 146.32B 21.97B 3.59B 3.21B 6.74
MDT 84.55 107.39B 33.00B 4.29B 5.50B 2.71
EW 69.67 41.01B 6.60B 4.16B 490.10M 2.34

Boston Scientific Corp Stock (BSX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-02-01 Aggiornamento Mizuho Neutral → Buy
2023-07-19 Iniziato Robert W. Baird Outperform
2023-06-30 Iniziato CL King Buy
2023-05-30 Ripresa Morgan Stanley Overweight
2023-03-29 Iniziato UBS Buy
2022-12-22 Iniziato Mizuho Neutral
2022-12-20 Ripresa Citigroup Buy
2022-10-18 Iniziato Barclays Overweight
2022-10-12 Iniziato Jefferies Buy
2022-07-06 Iniziato Wolfe Research Outperform
2022-05-27 Aggiornamento Needham Hold → Buy
2022-04-13 Ripresa Truist Buy
2022-03-02 Ripresa BofA Securities Buy
2021-12-10 Iniziato RBC Capital Mkts Outperform
2021-05-26 Downgrade Needham Buy → Hold
2021-05-25 Iniziato Barclays Overweight
2021-04-15 Iniziato Atlantic Equities Overweight
2020-09-17 Iniziato Truist Buy
2020-09-11 Iniziato Wolfe Research Peer Perform
2020-04-22 Downgrade SVB Leerink Outperform → Mkt Perform
2020-04-01 Aggiornamento Goldman Neutral → Buy
2020-03-05 Iniziato Citigroup Buy
2020-02-13 Iniziato Goldman Neutral
2020-02-06 Ripresa BTIG Research Buy
2019-12-30 Reiterato Cowen Outperform
2019-12-19 Downgrade Needham Strong Buy → Buy
2019-09-05 Ripresa JP Morgan Overweight
2019-09-03 Ripresa Barclays Overweight
2019-05-13 Aggiornamento Evercore ISI In-line → Outperform
2018-11-28 Iniziato UBS Buy
2018-10-16 Iniziato Barclays Overweight
2018-10-02 Reiterato Morgan Stanley Overweight
2018-09-07 Reiterato Needham Strong Buy
2018-09-04 Aggiornamento Jefferies Hold → Buy
2018-07-06 Reiterato Needham Strong Buy
2018-06-27 Iniziato Bernstein Outperform
2018-04-26 Reiterato Needham Strong Buy
Mostra tutto

Boston Scientific Corp Borsa (BSX) Ultime notizie

pulisher
Nov 20, 2024

Boston Scientific Corporation (BSX)’s Breakthroughs: A Hidden Gem in Billionaire Ken Griffin’s Portfolio - Insider Monkey

Nov 20, 2024
pulisher
Nov 20, 2024

Boston Scientific Co. (NYSE:BSX) Stake Boosted by PNC Financial Services Group Inc. - MarketBeat

Nov 20, 2024
pulisher
Nov 19, 2024

Boston Scientific Stock Set to Gain From Completion of Axonics Deal - Yahoo Finance

Nov 19, 2024
pulisher
Nov 18, 2024

Boston Sci study shows Watchman Flx better OPTION than DOAC - BioWorld Online

Nov 18, 2024
pulisher
Nov 18, 2024

Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch

Nov 18, 2024
pulisher
Nov 18, 2024

Boston Scientific Completes $3.7B Acquisition of Axonics - Orange County Business Journal

Nov 18, 2024
pulisher
Nov 18, 2024

Boston Scientific stock soars to all-time high of $89.33 - Investing.com

Nov 18, 2024
pulisher
Nov 18, 2024

Boston Scientific stock soars to all-time high of $89.33 By Investing.com - Investing.com Canada

Nov 18, 2024
pulisher
Nov 18, 2024

Here's Why We Think Boston Scientific (NYSE:BSX) Might Deserve Your Attention Today - Yahoo Finance

Nov 18, 2024
pulisher
Nov 18, 2024

Boston Scientific’s Watchman could be new option for patients post ablation: study - Yahoo Finance

Nov 18, 2024
pulisher
Nov 18, 2024

Boston Scientific acquires Axonics - Medical Buyer

Nov 18, 2024
pulisher
Nov 18, 2024

Boston Scientific reports outcomes from trial of LAAC device - Yahoo Finance

Nov 18, 2024
pulisher
Nov 17, 2024

Boston Scientific to Acquire Cortex - Today's Medical Developments

Nov 17, 2024
pulisher
Nov 16, 2024

Boston Scientific WATCHMAN FLX™ Left Atrial Appendage Closure Device Demonstrates Superior Bleeding Risk Reduction to Oral Anticoagulation Following a Cardiac Ablation in the OPTION Clinical Trial - Quantisnow

Nov 16, 2024
pulisher
Nov 15, 2024

Boston Scientific (BSX) Completes Acquisition of Axonics - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

Boston Scientific Corp. stock underperforms Friday when compared to competitors - MarketWatch

Nov 15, 2024
pulisher
Nov 15, 2024

Boston Scientific put volume heavy and directionally bearish - TipRanks

Nov 15, 2024
pulisher
Nov 15, 2024

Boston Scientific Closes $3.7B Deal for Axonics - MPO-mag

Nov 15, 2024
pulisher
Nov 15, 2024

Boston Scientific Closes Acquisition of Axonics, Inc. - Quantisnow

Nov 15, 2024
pulisher
Nov 15, 2024

Boston Scientific Closes Acquisition of Axonics, Inc. – Company Announcement - Financial Times

Nov 15, 2024
pulisher
Nov 15, 2024

Boston Scientific closes $3.7B Axonics deal after lengthy review - Yahoo Finance

Nov 15, 2024
pulisher
Nov 14, 2024

Boston Scientific Corp. stock underperforms Thursday when compared to competitors - MarketWatch

Nov 14, 2024
pulisher
Nov 14, 2024

SoniVie Names Axonics' Raymond Cohen as Chairman Following $3.7B Boston Scientific Deal | BSX Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 14, 2024

Boston Scientific Co. (NYSE:BSX) Shares Bought by Huntington National Bank - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Investing in Boston Scientific (NYSE:BSX) three years ago would have delivered you a 113% gain - Yahoo Finance

Nov 14, 2024
pulisher
Nov 13, 2024

Urology Devices Market to Surpass Market Valuation of USD 61.62 Billion by 2031 | SkyQuest Technology - Benzinga

Nov 13, 2024
pulisher
Nov 12, 2024

Boston Scientific EVP John Sorenson sells $2.68m in stock - Investing.com

Nov 12, 2024
pulisher
Nov 12, 2024

Boston Sci charges ahead with AVANT GUARD PFA trial - BioWorld Online

Nov 12, 2024
pulisher
Nov 12, 2024

Boston Scientific To Present At 2024 UBS Global Healthcare Conference; Webcast At 10:15 AM ET - Nasdaq

Nov 12, 2024
pulisher
Nov 11, 2024

Boston Scientific resumes enrolment in pulsed field ablation trial - Yahoo Finance

Nov 11, 2024
pulisher
Nov 11, 2024

BSXBoston Scientific Corp. Latest Stock News & Market Updates - StockTitan

Nov 11, 2024
pulisher
Nov 09, 2024

Boston Scientific Corporation (BSX): Among the Best Low Volatility Stocks to Invest In Now - Insider Monkey

Nov 09, 2024
pulisher
Nov 09, 2024

Boston Scientific Corporation (BSX): A Hot Growth Stock to Buy According to Hedge Funds - Insider Monkey

Nov 09, 2024
pulisher
Nov 09, 2024

Van ECK Associates Corp Has $5.06 Million Stock Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat

Nov 09, 2024
pulisher
Nov 08, 2024

8 Hot Growth Stocks To Buy According to Hedge Funds - Insider Monkey

Nov 08, 2024
pulisher
Nov 08, 2024

Boston Scientific stock soars to all-time high of $88.81 - Investing.com

Nov 08, 2024
pulisher
Nov 08, 2024

We Think Boston Scientific's (NYSE:BSX) Profit Is Only A Baseline For What They Can Achieve - Yahoo Finance

Nov 08, 2024
pulisher
Nov 08, 2024

Petri Dish: Boston Scientific resumes atrial fibrillation trial; Seaport hires CFO - The Business Journals

Nov 08, 2024
pulisher
Nov 07, 2024

Boston Scientific CEO sells shares worth $13.8 million By Investing.com - Investing.com Canada

Nov 07, 2024
pulisher
Nov 07, 2024

Boston Scientific CEO sells shares worth $13.8 million - Investing.com

Nov 07, 2024
pulisher
Nov 07, 2024

Boston Scientific Corp. stock rises Thursday, still underperforms market - MarketWatch

Nov 07, 2024
pulisher
Nov 07, 2024

Boston Scientific (BSX) Resumes AVANT GUARD Clinical Trial for A - GuruFocus.com

Nov 07, 2024
pulisher
Nov 07, 2024

Boston Scientific resumes AVANT GUARD trial - Investing.com

Nov 07, 2024
pulisher
Nov 07, 2024

Kidney Stone Management Market Forecast Report, 2024-2032Cook Group, Richard Wolf, Boston Scientific, and Dornier MedTech Actively Engaged in M&As to Increase Share - Yahoo Finance

Nov 07, 2024
pulisher
Nov 07, 2024

Boston Scientific Resumes AVANT GUARD Clinical Trial - TipRanks

Nov 07, 2024
pulisher
Nov 06, 2024

Boston Scientific Corp. stock rises Wednesday, still underperforms market - MarketWatch

Nov 06, 2024
pulisher
Nov 05, 2024

Boston Scientific Corp. stock rises Tuesday, still underperforms market - MarketWatch

Nov 05, 2024
pulisher
Nov 05, 2024

Boston Scientific to Speak at Conference - Baystreet.ca

Nov 05, 2024
pulisher
Nov 05, 2024

Boston Scientific to Participate in the 2024 UBS Global Healthcare Conference – Company Announcement - Financial Times

Nov 05, 2024
pulisher
Nov 05, 2024

Boston Scientific to bolster cardiac ablation portfolio with Cortex acquisition - Medical Device Network

Nov 05, 2024
pulisher
Nov 05, 2024

Heritage Investors Management Corp Sells 7,684 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat

Nov 05, 2024

Boston Scientific Corp Azioni (BSX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
medical_devices SYK
$385.91
price down icon 0.16%
medical_devices MDT
$84.18
price up icon 0.15%
medical_devices ABT
$115.37
price down icon 0.60%
medical_devices EW
$69.35
price down icon 1.08%
$84.31
price down icon 0.33%
Capitalizzazione:     |  Volume (24 ore):